The Infection Control Today® health care-acquired infections (HAIs) page presents updates on the latest techniques and strategies in the never-ending battle between infection preventionists and HAIs. Focusing on the latest in medical literature, we also present perspectives from the top infection preventionists and other medical experts in the country about how to put the growing knowledge of HAIs into use in the everyday world of infection prevention. Articles and videos often focus on methods to contain and control pathogens and multidrug-resistant organisms from spreading within the health care system.
March 7th 2024
Infection Control Today's® Product Locator is a column that highlights the latest advanced technology in infection prevention.
February 29th 2024
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
IPC Pros Helping Other: Engaging Staff Through an Infection Prevention and Control Educational Fair
August 3rd 2023In this installment of IPC Pros Helping Each Other, a long-term care infection preventionists in New Hampshire describes the IPC educational fair her facility organized for the rest of the staff. Michele M, director of nursing services, said, “[The educational fair] was a creative and interactive way to engage staff in infection control education.”
FDA Approves RSV Drug for Children Up to 24 Months
July 17th 2023AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
OIG's Adverse Events Toolkits: Preventing Patient Harm
July 17th 2023As an oversight agency for the Department of Health and Human Services, the Office of Inspector General is responsible for ensuring the safety and effectiveness of Medicare and Medicaid programs, with a huge priority being patient care. These toolkits provide additional guidance on how to avoid patient injury.
Pharmacists and Infection Preventionists: Collaboration on Antimicrobial Stewardship
July 3rd 2023A presentation at the APIC 2023 annual conference was about reducing the unnecessary treatment of asymptomatic bacteria, and the presenters shared some of the successful strategies they have implemented at their hospital.
APIC Conferences Are for IPs, but Who Else Would Benefit? Remastering Leadership Methods
June 26th 2023Infection preventions across the United States and the world converge at the annual APIC conference to learn the newest information on IPC. Read this article on who else should go to learn how to prevent and control infections.